Richard T. La (Co-founder and Chairman). Richard brings to GNUbiotics an immense wealth of corporate leadership experience, having served as CEO of Nobel Biocare, CEO of Nestlé Nutrition and CEO of Roche Consumer Health.
Jean-Philippe Kunz (Co-founder & CEO). Jean-Philippe is leading GNUbiotics by drawing on his 25 years’ international sale and business dev experience in consumer goods, pharmacy, nutrition and healthcare.
Yemi Adesokan, PhD (Co-founder & CSO). Yemi is the award winning scientific driving force behind GNUbiotics. He matches his scientific knowledge with a deep understanding of how early stage start-ups in the biotech and nutrition sector operate.
Bernardo Horta e Costa (Co-founder & CFO). Bernardo brings investment and financial transactions skills to GNUbiotics to ensure investors’ money is wisely invested.
Philippe Steenhout, MD Ped (Director, Medical Affairs). Expert in paediatric nutrition and gut microbiome. Philippe has more than 25 years with Nestlé Nutrition brings an immense knowledge of medical and clinical development to GNUbiotics.
Felix Previdoli, PhD (Director, Product Manufacturing). Felix brings his 35 years of experience in large scale chemical industry to lead the manufacturing set-up for GNUbiotics.
Mark Shepherd (Director, Marketing and Communications). Mark brings over 30 years’ experience in marketing and early consumer need understanding to help GNUbiotics work in partnership with customers to provide winning solutions.
SCIENTIFIC ADVISORY BOARD
Prof. Dr. Justin Sonnenburg. Associate Professor of Microbiology and Immunology at Stanford Medical School; Co-Director at Center for Human Microbiome Studies.
Prof. Dr. Dirk Haller, Director at the Institute for Food & Health (ZIEL); Chair for Nutrition and Immunology at the Technical University of Munich; Scientist at Nestlé Research Center; Lausanne, Switzerland.
Prof. Dr. Kelly Swanson is a world renown expert in companion animal nutrition, nutrigenomics and microbiomics. His research is focused on the effects of nutritional intervention on health outcomes, identifying mechanisms by which nutrients impact gastrointestinal microbiota, host gene expression, and host physiology, with primary emphasis on gastrointestinal health and obesity.
Prof. Dr. Richard Cummings Director, National Center for Functional Glycomics; Professor, Department of Surgery; Beth Israel Deaconess Medical Center, Harvard Medical School; Co-Founder of Selexys. (acquired by Novartis Nov 2016).